Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

2018 marks the 10 year anniversary since the Journal of Hematology & Oncology published its first article. Over the past decade, the journal has established itself in the top quartile of journals in both its fields worldwide.

To mark this occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 10 years.

Content type: Review
| 20 November 2018

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia

Authors: Yixin Zou, Wei Xu and Jianyong Li
Content type: Research
| 6 November 2018

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors

Authors: Cathy Zhou, Zilong Yuan, Weijie Ma, Lihong Qi, Angelique Mahavongtrakul, Ying Li, Hong Li, Jay Gong, Reggie R. Fan, Jin Li, Michael Molmen, Travis A. Clark, Dean Pavlick, Garrett M. Frampton, Brady Forcier, Elizabeth H. Moore…
Content type: Case report
| 22 October 2018

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma

Authors: Jinhuan Xu, Qiuxiang Wang, Hao Xu, Chaojiang Gu, Lijun Jiang, Jue Wang, Di Wang, Bin Xu, Xia Mao, Jin Wang, Zhiqiong Wang, Yi Xiao, Yicheng Zhang, Chunrui Li and Jianfeng Zhou
Content type: Research
| 20 October 2018

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

Authors: Florent Malard, Myriam Labopin, Christina Cho, Didier Blaise, Esperanza B. Papadopoulos, Jakob Passweg, Richard O’Reilly, Edouard Forcade, Molly Maloy, Liisa Volin, Hugo Castro-Malaspina, Yosr Hicheri, Ann A. Jakubowski, Corentin Orvain, Sergio Giralt, Mohamad Mohty…
Content type: Research
| 11 October 2018

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Authors: Xu Liang, Adrien Briaux, Véronique Becette, Camille Benoist, Anais Boulai, Walid Chemlali, Anne Schnitzler, Sylvain Baulande, Sofia Rivera, Marie-Ange Mouret-Reynier, Laurence Venat Bouvet, Thibaut De La Motte Rouge, Jérôme Lemonnier, Florence Lerebours and Céline Callens

Most recent articles RSS

View all articles

Content type: Review
| 22 March 2011

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Authors: Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
Content type: Review
| 10 June 2009

The effects of β-glucan on human immune and cancer cells

Authors: Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze
Content type: Review
| 25 February 2013

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Authors: Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang
Content type: Review
| 19 August 2013

Ibrutinib and novel BTK inhibitors in clinical development

Authors: Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu
Content type: Review
| 30 September 2013

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Authors: Li Shi, Shaohua Chen, Lijian Yang and Yangqiu Li

Most accessed articles RSS

View all articles

Nobel winner: Dr. James P. Allison

The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation." For a previously published work by Dr. Allison in Journal of Hematology & Oncology, see this article.

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

Articles

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

The effects of β-glucan on human immune and cancer cells

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Ibrutinib and novel BTK inhibitors in clinical development

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Nobel winner: Dr. James P. Allison

Aims and scope

Editor's quote

Experimental Hematology & Oncology

Official journal of

2017 Journal Metrics

Journal of Hematology & Oncology

Contact us